Facebook-f Instagram Twitter Youtube Whatsapp Tiktok Linkedin
Contact Us
iden

Our Publications

Prostem is committed to becoming a leading stem cell company in terms of quality and service both in Indonesia and Asia.

All
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Case Series: The Combination of Recommended Treatment Protocols with Add-On Secretome from Umbilical Cord-derived Mesenchymal Stem Cells (UC-MSCs) Therapy as a Medical Strategy for COVID-19 Treatment

Read More
The Combination Treatment of Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) and Secretome for Diabetic Foot Ulcer: A Case Report

Read More
Combination treatment of Umbilical Cord-derived Mesenchymal Stem Cell (UC-MSC) and Umbilical Cord Mesenchymal Stem Cell-derived Conditioned Medium (UCMSC-CM) for Keloid Post Chronic Burn Injury: A Case Report

Read More
Co-Culture Umbilical Cord Mesenchymal Stem Cells With Mononuclear Cells From Type 2 Diabetes Mellitus Patient Increase The Fgf-B, Gm-Csf Concentration

Read More
Msc-Derived Secretome Induced Glut4 Translocation In Hepg2 Insulin Resistance Model

Read More
Standard Regulation for Stem Cell Products in Indonesia.

Read More
Standard Regulation for Stem Cell Production in Indonesia

Read More
Potency of Mesenchymal Stem Cell and Its Secretome in Treating COVID-19

Read More
Multifocalelectroretinography Result before and after Peribulbar Injection of Allogeneic Umbilical Cord – Mesenchymal Stem Cell Secretome for Late-Stage Retinitis \Pigmentosa

Read More
1 2 3 … 10
Scroll to Top
Contact Us
prodia.stemcell@prostem.co.id
+62 821 1212 1416
+62 21 230 2629
+62 21 230 2642